Repare Therapeutics Inc.

NASDAQ:RPTX

1.32 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -34.406-34.77413.162-28.03-18.879-11.946-34.941-31.65875.461-38.093-34.757-28.29-30.892-26.309-21.417-15.263-13.751-11.802-12.601-8.331-7.688-6.359-4.838
Depreciation & Amortization 0.4780.4880.5010.5060.4980.5060.4410.4550.4840.5230.5160.3680.3690.4120.3220.2870.2070.2070.1960.1890.1540.140.122
Deferred Income Tax 000-10.799-1.87-2.09507.477-1.248-1.294-1.315-0.777-0.805-0.452-0.174-1.28-0.327-0.611.772-0.1970.09-0.5540.032
Stock Based Compensation 5.2486.5196.4756.3596.3776.2656.0625.1385.0534.7454.7553.8963.6933.1832.0571.0060.8710.3890.2710.1980.1270.1210.065
Change In Working Capital -1.14-1.647-7.502-5.899-19.547-27.621-2.116-6.4248.7175.4620.271.178-5.6924.6784.6260.864-7.28348.350.49-1.3760.711-0.1657.418
Accounts Receivables 0.336-0.21.11-0.7751.5471.753-2.5288.101-10.4080.015-0.404-0.1363.205-0.850.779-0.755-0.558-0.325-0.4-0.383-0.398-0.286-0.28
Change In Inventory 0003.3-1.547-1.753000-0.0150000000000000
Change In Accounts Payables 3.4710.3544.431-2.6530.1582.4132.016-8.4144.3683.47-0.7720.447-1.45-0.0461.2011.137-2.035-0.2721.187-0.3240.8970.2340.026
Other Working Capital -4.947-1.801-13.043-2.471-19.705-30.034-1.604-6.11122.0811.9921.0420.731-4.2424.7243.425-0.273-5.24848.622-0.697-1.052-0.186-0.3997.392
Other Non Cash Items -0.7196.2411.2329.7070.5510.545-1.232-4.6250.5520.4640.5252.8870.5540.430.3591.4390.1790.150.1550.1710.7550.7350.051
Operating Cash Flow -30.539-30.51411.932-28.156-32.87-34.346-31.786-29.63788.158-28.193-30.006-20.738-32.773-18.058-14.227-12.947-20.10436.684-9.717-9.346-5.851-6.0822.85
Investing Activities:
Investments In Property Plant And Equipment 000-0.3980-1.065-0.4751.72-0.266-1.569-0.487-0.165-0.324-0.429-0.772-1.721-0.473-0.013-0.03-0.743-0.181-0.3-0.08
Acquisitions Net 000-32.2770-29.4156.211-32.3380-0.2600.0400000000000
Purchases Of Investments -11.92-12.882-89.331-4.723-28.502-47.085-98.711-42.662-209.914-2.24-1.76-2.273-1.765-3.4380-7.5260000000
Sales Maturities Of Investments 432069.015375376.592.5751.252.52.6521.73.75000000000
Other Investing Activites 00-20.31632.27724.49829.415-6.21132.338-208.6640.260.890.04-0.0650.3120-7.5260000000
Investing Cash Flow 31.087.118-20.31631.87924.49828.35-6.68634.058-208.93-1.3090.403-0.398-0.389-0.117-0.772-9.247-0.473-0.013-0.03-0.743-0.181-0.3-0.08
Financing Activities:
Debt Repayment 00000000000000000000000
Common Stock Issued -0.37500.3750.1050.2840.040.4130.16500.2050.24194.2880.3630.4490.1832.5160000000
Common Stock Repurchased -11,288.42311,288.5890.358-10,030.4610000.433000.213000000000000
Dividends Paid 00000000000000000000000
Other Financing Activities 0.16600.3750.1050.2840.040.4130.1650.2690.2050.2410.2740.3630.4490.1830.2890.022249.0260.222082.248020.995
Financing Cash Flow 0.16600.3750.1050.2840.040.4130.1650.2690.2050.24194.5620.3630.4490.1830.289-1.695249.0260.222082.248020.995
Other Information:
Effect Of Forex Changes On Cash 0.014-0.001-0.0420.071-0.0870.039-0.001-0.256-0.14-0.0050.0710.006-0.059-0.0350.0340.2260.2150.532-1.5770.159-0.0750.526-0.044
Net Change In Cash 0.721-23.397-8.0513.899-8.175-5.917-38.064.33-120.643-29.302-29.29173.432-32.858-17.761-14.782-21.679-22.057286.229-11.102-9.9376.141-5.85623.721
Cash At End Of Period 80.54179.82103.217111.268107.369115.544121.461159.521155.191275.834305.136334.427260.995293.853311.614326.396348.075370.13283.90395.005104.93528.79434.65